Answers are grounded in this paper and cite their sources.
Langerhans cell histiocytosis is a rare proliferative disorder where pathologic Langerhans cells accumulate in a variety of organs. Historically, the nomenclature regarding this entity has been confusing because the disease had been subcategorized simply based upon the different clinical manifestations. In the following article, we summarize the current recommendation of the Histiocyte Society regarding the classification, evaluation, prognosis, and treatment of Langerhans cell histiocytosis.
No takes yet. Share an insight, caveat, or question.
Satter et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: